Genomic medicine study for kidney transplant patients
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at the genes of people who have had or will have a kidney transplant. It aims to learn how genetic information might help improve transplant care over time. Participants will give blood, urine, stool, and possibly kidney tissue samples for research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You can agree to take part in the study and be followed over time.
- You agree to give samples (blood, urine, stool, and possibly kidney tissue) for research.
- You have not had a stem cell or bone marrow transplant in the past 5 years.
- Your doctor does not expect you to live less than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study uses secure technology to combine health information and genetic data from children who have had liver or kidney transplants. The goal is to improve care and understanding of transplant outcomes in children.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study looks at how genes in the kidney change when the body might be rejecting the transplant. By studying these genes, doctors hope to find better ways to detect kidney rejection early and help keep the kidney healthy longer.
Hear when a new Transplant Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.